Brazil Ultrasound Devices Market Forecast 2031: Steady Growth Driven by Tech Innovation and Healthcare Access

The Brazil ultrasound devices market is on a trajectory of robust and sustained growth, poised to evolve from a valued USD 246.51 million in 2025 to USD 258.59 million in 2026, and further surge to USD 328.47 million by 2031 at a compound annual growth rate (CAGR) of 4.90% over the forecast period. This growth story is underpinned by transformative healthcare policies, rapid technological advancements, and shifting demand dynamics across the country’s diverse healthcare landscape, with key segments redefining market trends and opening new avenues for industry players.

By application, gynecology/obstetrics (OB-GYN) remains the undisputed market leader, holding a 27.21% revenue share in 2025—a position solidified by Brazil’s high teenage pregnancy rates and mandatory prenatal screening protocols that drive consistent demand for OB-GYN ultrasound devices. While maternal health continues to anchor the market, anesthesiology is emerging as the fastest-growing application segment, set to expand at a remarkable 7.78% CAGR from 2026 to 2031. This growth is fueled by the rising adoption of ultrasound-guided procedures in surgical and critical care settings, enhancing precision and patient safety across Brazilian healthcare facilities.

Technological innovation is the cornerstone of the market’s evolution, with 3D & 4D imaging technologies dominating the landscape in 2025, capturing 45.60% of the market share. These advanced imaging solutions have become a staple in fetal and diagnostic imaging, offering unparalleled visualization for healthcare providers. However, AI-enabled/automated ultrasound systems are stealing the spotlight as the next big disruptor, projected to grow at an 8.79% CAGR over the forecast period. The integration of artificial intelligence streamlines diagnostic workflows, reduces reliance on highly specialized sonographers, and improves the accuracy of readings—critical advantages for a country grappling with healthcare workforce disparities across urban and rural regions.

Portability is redefining access paradigms in Brazil’s ultrasound market, a shift that mirrors the global push for point-of-care diagnostics. In 2025, stationary ultrasound systems still held a dominant 69.70% market share, favored by large hospitals and urban imaging centers for their advanced capabilities. Yet, handheld and wireless scanners are experiencing explosive growth, set to climb at a staggering 10.72% CAGR through 2031. This surge is directly linked to Brazil’s Telessaúde Brasil network, a flagship telehealth initiative under the country’s Unified Health System (SUS) that has expanded tele-ultrasound coverage to remote municipalities, where portable devices enable real-time diagnostic support and reduce the need for patient travel to urban hubs. As of 2025, the SUS telehealth network had completed over 4.6 million teleconsultations, with ultrasound at the heart of its diagnostic services, and 2026 expansions in Minas Gerais—including 216 telehealth kits across 122 cities—are set to further boost demand for portable solutions.

By end user, hospitals remain the largest segment, accounting for 42.74% of the market share in 2025, thanks to their extensive diagnostic and treatment capabilities. However, diagnostic imaging centers are the fastest-growing end user, projected to grow at a 7.23% CAGR. This trend is driven by the rise of private diagnostic chains and imaging hubs in Brazil, which are filling gaps in healthcare access, especially in secondary cities, and offering affordable, specialized ultrasound services complementing public healthcare provisions. Public-private collaborations to expand screening programs for cardiovascular diseases, thyroid disorders, and fetal health have further amplified the role of independent imaging centers in the market.

A confluence of drivers is propelling this growth, beyond telehealth and technological adoption. Mandatory cardiac screening for professional athletes has spurred demand for cardiovascular ultrasound devices, while the Brazilian government’s USD 480 million investment in 2025 to acquire over 10,000 medical devices—including portable ultrasound machines—aims to boost domestic healthcare self-sufficiency from 45% to 50% by 2026, further stimulating market demand. Additionally, growing public awareness of preventive healthcare and the expansion of chronic disease management programs have increased the volume of ultrasound screenings for conditions like diabetes-related vascular issues and musculoskeletal disorders.

Amid this growth, global players like Periodmed are playing a pivotal role in shaping Brazil’s ultrasound market, bringing a full range of innovative solutions tailored to the country’s diverse needs. With two R&D centers in Shenzhen and Xuzhou, a 30,000-square-meter intelligent manufacturing base, and a fully integrated industry chain (including mold, injection molding, SMT, and assembly), Periodmed delivers high-quality, cost-competitive ultrasound devices—from AI-powered musculoskeletal and neck ultrasound systems to portable OB-GYN and fetal ultrasound machines, and 3D/4D premium diagnostic systems. Its 90% automation rate in SMT production and lean manufacturing lines ensure consistent supply, while flexible customized production capabilities cater to the unique requirements of Brazilian public and private healthcare providers. Periodmed’s portfolio aligns perfectly with Brazil’s market trends, offering the handheld, AI-enabled, and specialized ultrasound devices that are driving the country’s market growth.

While the market’s outlook is bright, it is not without challenges. Brazil’s regulatory framework for medical devices—overseen by ANVISA—requires rigorous registration for high-risk ultrasound devices (Class III/IV), including local representation and compliance with Brazilian Good Manufacturing Practices (B-GMP), which can create entry barriers for new players. Additionally, healthcare infrastructure disparities between Brazil’s southeast (which holds 54% of current ultrasound installations) and the north/northeast regions mean market penetration remains uneven, though government incentives are accelerating deployments in underserved areas.

In conclusion, the Brazil ultrasound devices market from 2026 to 2031 is defined by steady growth, driven by tech innovation, telehealth expansion, and evolving healthcare needs. The rise of AI and portable solutions, coupled with the growing role of private imaging centers and government investments, is reshaping the market, while players like Periodmed are well-positioned to meet the demand for high-quality, accessible ultrasound technology. As Brazil continues to modernize its healthcare system and expand access to diagnostic services, the ultrasound devices market will remain a critical pillar of the country’s healthcare transformation, delivering improved patient outcomes across urban and remote communities alike.